Immune-related adverse events and the balancing act of immunotherapy by Michael Conroy, Jarushka Naidoo

Get full text

Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity by Christopher Cluxton, Jarushka Naidoo

Get full text

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs by Aanika Balaji, Jiajia Zhang, Jarushka Naidoo

Get full text

Toxicity of immune checkpoint inhibitors and tyrosine kinase inhibitor combinations in solid tumours: a systematic review and meta-analysis by David O’Reilly, David O’Reilly, David O’Reilly, Caroline L. O’Leary, Aislinn Reilly, Min Yuen Teo, Grainne O’Kane, Lizza Hendriks, Kathleen Bennett, Jarushka Naidoo, Jarushka Naidoo, Jarushka Naidoo

Get full text

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer by Taiseer Al-Rajabi, Jarushka Naidoo, Jun Zhang, Jun Zhang

Get full text

855 Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses by Shannon Wongvibulsin, Jarushka Naidoo, Yevgeniy Semenov, Shawn Kwatra, Thomas Le, Subuhi Kaul, Laura Cappelli

Corticosteroid-resistant immune-related adverse events: a systematic review by Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Läubli, David König, Eveline Daetwyler, Till Wallrabenstein

Get full text

Sex-specific differences in immunogenomic features of response to immune checkpoint blockade by Susan C. Scott, Xiaoshan M. Shao, Xiaoshan M. Shao, Noushin Niknafs, Archana Balan, Gavin Pereira, Kristen A. Marrone, Vincent K. Lam, Joseph C. Murray, Josephine L. Feliciano, Benjamin P. Levy, David S. Ettinger, Christine L. Hann, Julie R. Brahmer, Patrick M. Forde, Rachel Karchin, Rachel Karchin, Rachel Karchin, Jarushka Naidoo, Jarushka Naidoo, Jarushka Naidoo, Valsamo Anagnostou

Get full text

Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma by Jarushka Naidoo, Evan Lipson, Samuel Rosner, Nafi Aygun, Yuri Agrawal, Daniel Q Sun, Megan D Schollenberger

Get full text

2568 Pembrolizumab for patients with leptomeningeal disease from advanced solid tumors by Jarushka Naidoo, Chen Hu, Karisa Schrek, Roisin Connolly, Cesar Santa-Maria, Evan Lipson, Ranee Mehra, Bettegowda, Kristin Redmond, Arun Venkatesan, Stuart Grossman

Get full text

Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management by Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Mizuki Nishino, David Feller-Kopman, Karthik Suresh, Joshua E Reuss, Seema Mehta Steinke, Clare Rock, Douglas B Johnson

Get full text

Correlation of safety and efficacy of atezolizumab therapy across indications by Jarushka Naidoo, Guru Sonpavde, Mark A Socinski, Rajat Mohindra, Corey Carter, Laurent Essioux, Gonzalo Durán-Pacheco, G Scott Chandler, Vidya Maiya, Javier Puente, Jose Vicente Cardona

Get full text

Use of artificial intelligence chatbots in clinical management of immune-related adverse events by Jarushka Naidoo, Igor Puzanov, Paolo A Ascierto, Marc S Ernstoff, Douglas B Johnson, Fei Ye, Mitchell S von Itzstein, David E Gerber, Benjamin Switzer, Aliyah Pabani, Hannah Burnette, Run Fan

Get full text

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series by Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli

Get full text

Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors. by Kathryn C Arbour, Jarushka Naidoo, Keith E Steele, Ai Ni, Andre L Moreira, Natasha Rekhtman, Paul B Robbins, Joyson Karakunnel, Andreas Rimner, James Huang, Gregory J Riely, Matthew D Hellmann

Get full text

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes by Lei Zheng, Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Cheng Ting Lin, Peter B Illei, Sonye K Danoff, Karthik Suresh, Christine Hann, Aanika Balaji, Melinda Hsu, Josephine Feliciano, Kristen Marrone, Valerie Lee

Get full text

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers. by Bob T Li, Emil Lou, Meier Hsu, Helena A Yu, Jarushka Naidoo, Marjorie G Zauderer, Camelia Sima, Melissa L Johnson, Mariza Daras, Lisa M DeAngelis, Martin Fleisher, Mark G Kris, Christopher G Azzoli

Get full text

Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study by Jarushka Naidoo, Ryan Sullivan, Meghan J Mooradian, Leyre Zubiri, Vartan Pahalyants, Nicholas Theodosakis, Kerry L Reynolds, Yevgeniy R Semenov, Meghan E Sise, James Iheke, Pearl Ugwu-Dike, Jayhyun Seo, Kimberly Tang, Bruce C Tiu

Get full text

Genomic Landscape of NSCLC in the Republic of Ireland by Rachel J. Keogh, MB BCH BAO, Martin P. Barr, PhD, Anna Keogh, MB BCH BAO, David McMahon, MB BCH BAO, Cathal O’Brien, PhD, Stephen P. Finn, MD, Jarushka Naidoo, MBBCH, MHS

Get full text

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors by Jarushka Naidoo, Maria L Ascierto, Matthew D Hellmann, Ding Wang, Susana Banerjee, Mayukh Das, Panagiotis Kourtesis, Jennifer R Diamond, Teresa Alonso-Gordoa, Sandip P Patel, Nathan E Standifer, Doug C Palmer, Lin-Yang Cheng, Benedito A Carneiro

Get full text